General Information of Drug Transporter (DT)
DT ID DTD0231 Transporter Info
Gene Name SLC26A3
Transporter Name Chloride anion exchanger
Gene ID
1811
UniProt ID
P40879
Post-Translational Modification of This DT
Overview ofSLC26A3 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Critically important for effective cell surface expression of SLC26A3 and protects it from degradation by proteases [1]

Role of PTM

Degradation via Proteosome

Modified Residue

Asparagine

Modified Location

165

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-glycosylation at SLC26A3 Asparagine 165 have been reported to be critically important for its effective cell surface expression and protects it from degradation by proteases.

  PTM Phenomenon2

Increasing the cell surface expression of SLC26A3 [1]

Role of PTM

Surface Expression Modulation

Modified Residue

Asparagine

Modified Location

153

Experimental Material(s)

Chinese hamster ovary (CHO) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-glycosylation at SLC26A3 Asparagine 153 have been reported to increase its cell surface expression.

  PTM Phenomenon3

Increasing the cell surface expression of SLC26A3 [1]

Role of PTM

Surface Expression Modulation

Modified Residue

Asparagine

Modified Location

161

Experimental Material(s)

Chinese hamster ovary (CHO) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-glycosylation at SLC26A3 Asparagine 161 have been reported to increase its cell surface expression.

Phosphorylation

  Serine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC26A3 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

242

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Serine 242 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC26A3 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

362

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Serine 362 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC26A3 [3], [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

509

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Serine 509 has the potential to affect its expression or activity.

  PTM Phenomenon4

Have the potential to influence SLC26A3 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

563

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Serine 563 has the potential to affect its expression or activity.

  PTM Phenomenon5

Have the potential to influence SLC26A3 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

727

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Serine 727 has the potential to affect its expression or activity.

  PTM Phenomenon6

Have the potential to influence SLC26A3 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

729

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Serine 729 has the potential to affect its expression or activity.

  PTM Phenomenon7

Have the potential to influence SLC26A3 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

734

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Serine 734 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC26A3 [3], [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

503

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Threonine 503 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC26A3 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

728

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Threonine 728 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC26A3 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

744

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Threonine 744 has the potential to affect its expression or activity.

  PTM Phenomenon4

Have the potential to influence SLC26A3 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

747

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Threonine 747 has the potential to affect its expression or activity.

  Tyrosine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC26A3 [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

9

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Tyrosine 9 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC26A3 [3], [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

520

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Tyrosine 520 has the potential to affect its expression or activity.

  PTM Phenomenon3

. [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

526

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Tyrosine 526 has the potential to affect its expression or activity.

  PTM Phenomenon4

Have the potential to influence SLC26A3 [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

726

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Tyrosine 726 has the potential to affect its expression or activity.

  PTM Phenomenon5

Have the potential to influence SLC26A3 [9]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

756

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A3 Tyrosine 756 has the potential to affect its expression or activity.
References
1 Role of N-glycosylation in cell surface expression and protection against proteolysis of the intestinal anion exchanger SLC26A3. Am J Physiol Cell Physiol. 2012 Mar 1;302(5):C781-95.
2 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
4 ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007 May 25;316(5828):1160-6.
5 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
6 Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
7 Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
8 15 years of PhosphoSitePlus?: integrating post-translationally modified sites, disease variants and isoforms. Nucleic Acids Res. 2019;47(D1):D433-D441.
9 Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection. J Proteomics. 2017 Jun 6;162:99-107.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.